Peter Fernandes

Vorsitzender bei The Pulmonary Vascular Research Institute

Vermögen: 2 079 $ am 31.05.2024

69 Jahre

Health Technology

Consumer Services

Commercial Services

Aktive Positionen von Peter Fernandes

Unternehmen	Position	Beginn	Ende
The Pulmonary Vascular Research Institute The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK.	Vorsitzender	-	-

Unternehmen	Position	Beginn	Ende
BELLEROPHON THERAPEUTICS, INC.	Comptroller/Controller/Auditor	05.05.2023	15.11.2023
	Vorstandsvorsitzender	11.11.2021	15.11.2023
	Finanzdirektor/CFO	05.05.2023	15.11.2023
	General Counsel	20.05.2015	15.11.2023
IKARIA, INC.	General Counsel	01.10.2012	01.05.2015
OPTINOSE, INC.	General Counsel	01.10.2010	01.09.2012
Novartis Pharmaceuticals AG	Corporate Officer/Principal	01.11.2007	01.10.2010
ALTANA Pharma US, Inc. ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ.	General Counsel	01.02.2005	01.10.2007

The Grant Government Medical College	Graduate Degree
Principal K. M. Kundnani College of Pharmacy	Undergraduate Degree

International

Operativ

General Counsel	4
Comptroller/Controller/Auditor	1
Chief Executive Officer	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
BELLEROPHON THERAPEUTICS, INC.	Health Technology
OPTINOSE, INC.	Health Technology

Private Unternehmen	4
Ikaria, Inc. Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ.	Health Technology
ALTANA Pharma US, Inc. ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ.	Health Technology
Novartis Pharmaceuticals AG
The Pulmonary Vascular Research Institute The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK.	Commercial Services